Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Phase-II study of Navelbine in advanced breast cancer.

× No keyword cloud information.

23 in total

1. Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines.

Authors: Kaisa Erjala; Misa Raitanen; Jarmo Kulmala; Reidar Grénman
Journal: J Cancer Res Clin Oncol Date: 2006-10-05 Impact factor: 4.553

Review 2. Clinical pharmacokinetics of vinorelbine.

Authors: D Levêque; F Jehl
Journal: Clin Pharmacokinet Date: 1996-09 Impact factor: 6.447

3. Vinorelbine: an active, non cross-resistant drug in advanced breast cancer. Results from a phase II study.

Authors: M Terenziani; R Demicheli; C Brambilla; L Ferrari; A Moliterni; M Zambetti; A Caraceni; C Martini; G Bonadonna
Journal: Breast Cancer Res Treat Date: 1996 Impact factor: 4.872

Review 4. Vinorelbine. A review of its pharmacological properties and clinical use in cancer chemotherapy.

Authors: K L Goa; D Faulds
Journal: Drugs Aging Date: 1994-09 Impact factor: 3.923

5. Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study.

Authors: John F Kuttesch; Mark D Krailo; Timothy Madden; Mary Johansen; Archie Bleyer
Journal: Pediatr Blood Cancer Date: 2009-10 Impact factor: 3.167

Review 6. The current and future place of vinorelbine in cancer therapy.

Authors: E Cvitkovic; J Izzo
Journal: Drugs Date: 1992 Impact factor: 9.546

7. Biliary elimination and pharmacokinetics of vinorelbine in micropigs.

Authors: D Levêque; M Merle-Melet; L Bresler; J P Didelot; J P Aymard; J Wihlm; F Jehl
Journal: Cancer Chemother Pharmacol Date: 1993 Impact factor: 3.333

8. Plasma pharmacokinetics, tissue disposition, excretion and metabolism of vinorelbine in mice as determined by high performance liquid chromatography.

Authors: O van Tellingen; A V Kuijpers; J H Beijnen; W J Nooijen; A Bult
Journal: Invest New Drugs Date: 1993 May-Aug Impact factor: 3.850

9. Pulmonary distribution of vinorelbine in patients with non-small-cell lung cancer.

Authors: D Levêque; E Quoix; P Dumont; G Massard; J G Hentz; A Charloux; F Jehl
Journal: Cancer Chemother Pharmacol Date: 1993 Impact factor: 3.333

Review 10. Management of metastatic breast cancer.

Authors: K Wong; I C Henderson
Journal: World J Surg Date: 1994 Jan-Feb Impact factor: 3.352